Topics
May/June 2019 | Special Reports
Update on DRCR Retina Network Protocols
Recent results and ongoing trials shed light on the world of diabetic eye disease.
Chirag Jhaveri, MD
June 19, 2026
Potential Drug Signals Linked to Wet AMD Identified in Integrative Analysis
Foundation Fighting Blindness Receives $1 Million Commitment to Advance Gene-Agnostic IRD Therapies
June 18, 2026
Ocular Therapeutix Aligns with FDA on Planned Axpaxli NDA Submission for Wet AMD
June 17, 2026
Bayer Completes Acquisition of Perfuse Therapeutics, Gains Full Rights to PER-001
May/June 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Supported by Zeiss
Editorially independent supported by Abbvie and Regenxbio
May/June 2026 Supplement
Free Print Subscription
Email Newsletter
Conference Calendar
